Brief: Aligos Therapeutics Announces $92 Million Private Placement Financing
Oct 23 (Reuters) - Aligos Therapeutics Inc ALGS.O :
* ALIGOS THERAPEUTICS ANNOUNCES $92 MILLION PRIVATE
PLACEMENT
FINANCING
* ALIGOS THERAPEUTICS INC: FUNDING EXPECTED TO EXTEND CASH
RUNWAY
THROUGH END OF 2025
* ALIGOS THERAPEUTICS: CO BELIEVES CASH, CASH EQUIVALENTS
AND
INVESTMENTS, WILL PROVIDE SUFFICIENT FUNDING OF PLANNED
OPERATIONS THROUGH END OF 2025.
Source text for Eikon: ID:nGNXtmDjP
Further company coverage: ALGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aligos Therapeutics
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
U.S. RESEARCH ROUNDUP-Ciena Corp, Docusign, Snowflake
Brief: Aligos Therapeutics Announces First Participant Dosed In The Phase 1 Study Of Its Potentially Best-In-Class Antisense Oligonucleotide Alg-170675 By Its Partner Amoytop In China
Aligos Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aligos Therapeutics Q2 net loss narrows on licensing revenue